Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Debasish Kumar Ghosh, Akshaykumar Nanaji Shrikondawar & Akash Ranjan. (2020) Local structural unfolding at the edge-strands of beta sheets is the molecular basis for instability and aggregation of G85R and G93A mutants of superoxide dismutase 1. Journal of Biomolecular Structure and Dynamics 38:3, pages 647-659.
Read now
Read now
Shen Luo, Keisha Melodi McSweeney, Tao Wang, Silvia M. Bacot, Gerald M. Feldman & Baolin Zhang. (2020) Defining the right diluent for intravenous infusion of therapeutic antibodies. mAbs 12:1.
Read now
Read now
Shen Luo & Baolin Zhang. (2015) Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins. mAbs 7:6, pages 1094-1103.
Read now
Read now
Tudor Arvinte, Caroline Palais, Erin Green-Trexler, Sonia Gregory, Henryk Mach, Chakravarthy Narasimhan & Mohammed Shameem. (2013) Aggregation of biopharmaceuticals in human plasma and human serum. mAbs 5:3, pages 491-500.
Read now
Read now
Rabah Gahoual, Alicia Burr, Jean-Marc Busnel, Lauriane Kuhn, Phillipe Hammann, Alain Beck, Yannis-Nicolas François & Emmanuelle Leize-Wagner. (2013) Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry. mAbs 5:3, pages 479-490.
Read now
Read now
Bas J.M. Peters, Martinus A.H. Capelle, Tudor Arvinte & Ewoudt M.W. van de Garde. (2013) Validation of an automated method for compounding monoclonal antibody patient doses. mAbs 5:1, pages 162-170.
Read now
Read now
Veysel Kayser, Naresh Chennamsetty, Vladimir Voynov, Bernhard Helk & Bernhardt L. Trout. (2011) Conformational stability and aggregation of therapeutic monoclonal antibodies studied with ANS and Thioflavin T binding. mAbs 3:4, pages 408-411.
Read now
Read now
Articles from other publishers (52)
Maarten Swart, Harmjan Kuipers, Fin Milder, Mandy Jongeneelen, Tina Ritschel, Jeroen Tolboom, Leacky Muchene, Joan van der Lubbe, Ana Izquierdo Gil, Daniel Veldman, Jeroen Huizingh, Johan Verspuij, Sonja Schmit-Tillemans, Sven Blokland, Martijn de Man, Ramon Roozendaal, Christopher B. Fox, Hanneke Schuitemaker, Martinus Capelle, Johannes P. M. Langedijk, Roland Zahn & Boerries Brandenburg. (2023) Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen. npj Vaccines 8:1.
Crossref
Crossref
V. Ashutosh Rao. 2023. Surfactants in Biopharmaceutical Development. Surfactants in Biopharmaceutical Development
169
178
.
Kaimin Gao, Hong Lian, Chengfeng Xue, Jing Zhou & Xiaomei Yan. (2022) High-Throughput Counting and Sizing of Therapeutic Protein Aggregates in the Nanometer Size Range by Nano-Flow Cytometry. Analytical Chemistry 94:50, pages 17634-17644.
Crossref
Crossref
Alexandra Roesch, Sarah Zölls, Daniela Stadler, Constanze Helbig, Klaus Wuchner, Gideon Kersten, Andrea Hawe, Wim Jiskoot & Tim Menzen. (2022) Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. Journal of Pharmaceutical Sciences 111:4, pages 933-950.
Crossref
Crossref
Yoann Le Basle, Philip Chennell, Nicolas Tokhadze, Alain Astier & Valérie Sautou. (2020) Physicochemical Stability of Monoclonal Antibodies: A Review. Journal of Pharmaceutical Sciences 109:1, pages 169-190.
Crossref
Crossref
Tudor Arvinte, Caroline Palais, Emilie Poirier, Amelia Cudd, Shanthi Rajendran, Stephen Brokx & Jason Dowd. (2019) Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate. Journal of Pharmaceutical and Biomedical Analysis 176, pages 112802.
Crossref
Crossref
Yu-Wen Lo, Ming-Thau Sheu, Wen-Hsuan Chiang, Ya-Ling Chiu, Chia-Mu Tu, Wen-Yu Wang, Ming-Hsi Wu, Yu-Cheng Wang, Maggie Lu & Hsiu-O Ho. (2019) In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer. Acta Biomaterialia 86, pages 280-290.
Crossref
Crossref
Ziya Sahin, Ronald Neeleman, Jonathan Haines & Veysel Kayser. (2019) Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines. Vaccine 37:8, pages 1073-1079.
Crossref
Crossref
Bahar Demirdirek, Wenkui Lan, Difei Qiu, Wei Ding, Lavanya K. Iyer, Mark S. Bolgar & Joseph J. Valente. (2019) Comparison of imaged capillary isoelectric focusing and cation exchange chromatography for monitoring dextrose-mediated glycation of monoclonal antibodies in infusion solutions. Journal of Chromatography B 1105, pages 156-163.
Crossref
Crossref
Sheun Oshinbolu, Rachana Shah, Gary Finka, Mike Molloy, Mark Uden & Daniel G Bracewell. (2018) Evaluation of fluorescent dyes to measure protein aggregation within mammalian cell culture supernatants. Journal of Chemical Technology & Biotechnology 93:3, pages 909-917.
Crossref
Crossref
Hoda E. Mohamed, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla & Samah S. Abbas. (2018) Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol. Journal of Pharmaceutical and Biomedical Analysis 150, pages 268-277.
Crossref
Crossref
Ghaith AlTawallbeh, Mohammad M. Haque, Kiril A. Streletzky, Dennis J. Stuehr & Mekki Bayachou. (2017) Endothelial nitric oxide synthase oxygenase on lipid nanodiscs: A nano-assembly reflecting native-like function of eNOS. Biochemical and Biophysical Research Communications 493:4, pages 1438-1442.
Crossref
Crossref
Camilla De Nardis, Linda J.A. Hendriks, Emilie Poirier, Tudor Arvinte, Piet Gros, Alexander B.H. Bakker & John de Kruif. (2017) A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1. Journal of Biological Chemistry 292:35, pages 14706-14717.
Crossref
Crossref
Kinjal A. Patel, Ratnika Sethi, Anita R. Dhara & Ipsita Roy. (2017) Challenges with osmolytes as inhibitors of protein aggregation: Can nucleic acid aptamers provide an answer?. International Journal of Biological Macromolecules 100, pages 75-88.
Crossref
Crossref
Nathaniel R. Maddux, Austin L. Daniels & Theodore W. Randolph. (2017) Microflow Imaging Analyses Reflect Mechanisms of Aggregate Formation: Comparing Protein Particle Data Sets Using the Kullback–Leibler Divergence. Journal of Pharmaceutical Sciences 106:5, pages 1239-1248.
Crossref
Crossref
Ziya Sahin, Senem Akkoc, Ronald Neeleman, Jonathan Haines & Veysel Kayser. (2017) Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines. Vaccine 35:23, pages 3026-3032.
Crossref
Crossref
Neha N. Pardeshi, Wei Qi, Kevin Dahl, Liron Caplan & John F. Carpenter. (2017) Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product. Journal of Pharmaceutical Sciences 106:2, pages 511-520.
Crossref
Crossref
Neshatul Haque, Krishnakanth Baratam & N. Prakash Prabhu. (2017) Analysing the microenvironment of 2-p-toluidinylnaphthalene-6-sulfonate (TNS) in solvents and in different conformational states of proteins in relation to its fluorescence properties: a computational study. Physical Chemistry Chemical Physics 19:36, pages 24656-24666.
Crossref
Crossref
Carmen R.M. Bria & S. Kim Ratanathanawongs Williams. (2016) Impact of asymmetrical flow field-flow fractionation on protein aggregates stability. Journal of Chromatography A 1465, pages 155-164.
Crossref
Crossref
Ziya Sahin, Yusuf Kemal Demir & Veysel Kayser. (2016) Global kinetic analysis of seeded BSA aggregation. European Journal of Pharmaceutical Sciences 86, pages 115-124.
Crossref
Crossref
Anacelia R?os Quiroz, Jens Lamerz, Thierry Da Cunha, Adeline Boillon, Michael Adler, Christof Finkler, Joerg Huwyler, Roland Schmidt, Hanns-Christian Mahler & Atanas V. Koulov. (2015) Factors Governing the Precision of Subvisible Particle Measurement Methods ? A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe. Pharmaceutical Research 33:2, pages 450-461.
Crossref
Crossref
Arne Schön, Benjamin R. Clarkson, Rogelio Siles, Patrick Ross, Richard K. Brown & Ernesto Freire. (2015) Denatured state aggregation parameters derived from concentration dependence of protein stability. Analytical Biochemistry 488, pages 45-50.
Crossref
Crossref
Satish K. Singh, Donna L. Luisi & Roger H. Pak. (2015) Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability. Pharmaceutical Research 32:11, pages 3541-3571.
Crossref
Crossref
Maureen Deehan, Sandra Garc?s, Daniel Kramer, Matthew P. Baker, Dorothea Rat, Yvonne Roettger & Arno Kromminga. (2015) Managing unwanted immunogenicity of biologicals. Autoimmunity Reviews 14:7, pages 569-574.
Crossref
Crossref
P. Arora, S. Paratkar & R. Gandhi. (2015) High Throughput Fluorescence Assay to Detect Aggregation During Biologics Formulation Development. Journal of Pharmaceutical Innovation 10:2, pages 109-117.
Crossref
Crossref
Ajay Banga. 2015. Therapeutic Peptides and Proteins. Therapeutic Peptides and Proteins
147
182
.
Jessica M Baron, Bonnie L Boster & Chad M Barnett. (2014) Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer. Journal of Oncology Pharmacy Practice 21:2, pages 132-142.
Crossref
Crossref
Tudor Arvinte, Emilie Poirier & Caroline Palais. 2015. Biobetters. Biobetters
91
104
.
Anja Fincke, Jonas Winter, Thomas Bunte & Carsten Olbrich. (2014) Thermally induced degradation pathways of three different antibody-based drug development candidates. European Journal of Pharmaceutical Sciences 62, pages 148-160.
Crossref
Crossref
Michael Wagner, Stephan Holzschuh, Anja Traeger, Alfred Fahr & Ulrich. S. Schubert. (2014) Asymmetric Flow Field-Flow Fractionation in the Field of Nanomedicine. Analytical Chemistry 86:11, pages 5201-5210.
Crossref
Crossref
Remant Bahadur K.C., Varun Chandrashekaran, Bei Cheng, Hexin Chen, Maria Marjorette O. Peña, Jiajia Zhang, Janis Montgomery & Peisheng Xu. (2014) Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells. Molecular Pharmaceutics 11:6, pages 1897-1905.
Crossref
Crossref
Dashnor Nebija, Christian Noe, Ernst Urban & Bodo Lachmann. (2014) Quality Control and Stability Studies with the Monoclonal Antibody, Trastuzumab: Application of 1D- vs. 2D-Gel Electrophoresis. International Journal of Molecular Sciences 15:4, pages 6399-6411.
Crossref
Crossref
Zahra Shahrokh, Nazila Salamat‐Miller & John J. Thomas. 2014. Biophysical Methods for Biotherapeutics. Biophysical Methods for Biotherapeutics
317
353
.
Koen Sandra, Isabel Vandenheede & Pat Sandra. (2014) Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization. Journal of Chromatography A 1335, pages 81-103.
Crossref
Crossref
Napoleon Tercero & Joseph Kotarek. (2014) Voltammetric Monitoring of Protein Aggregation from Solution Using Tris-(2,2′-Bipyridine) Osmium(II) Chloride Complex as an Electrocatalytic Mediator. Electroanalysis 26:2, pages 243-247.
Crossref
Crossref
Atiyatul Qadeer, Ejaz Ahmad, Masihuz Zaman, Mohd Wasif Khan, Javed Masood Khan, Gulam Rabbani, Khaja Faisal Tarique, Gaurav Sharma, Samudrala Gourinath, Sajid Nadeem, Gamal Badr & Rizwan Hasan Khan. (2013) Concentration-dependent antagonistic persuasion of SDS and naphthalene derivatives on the fibrillation of stem bromelain. Archives of Biochemistry and Biophysics 540:1-2, pages 101-116.
Crossref
Crossref
Hanieh Khalili, Antony Godwin, Ji-won Choi, Rebecca Lever, Peng T. Khaw & Steve Brocchini. (2013) Fab-PEG-Fab as a Potential Antibody Mimetic. Bioconjugate Chemistry 24:11, pages 1870-1882.
Crossref
Crossref
Satish K. Singh. 2013. Sterile Product Development. Sterile Product Development
359
409
.
Tingting Wang, Sangeeta B. Joshi, Ozan S. Kumru, Srivalli Telikepalli, C. Russell Middaugh & David B. Volkin. 2013. Biophysics for Therapeutic Protein Development. Biophysics for Therapeutic Protein Development
205
243
.
Sreedhara Alavattam, Barthelemy Demeule, Jun Liu, Sandeep Yadav, Mary Cromwell & Steven J. Shire. 2013. Biophysics for Therapeutic Protein Development. Biophysics for Therapeutic Protein Development
173
204
.
Brett L. Mellor, Stephen J. Wood & Brian A. Mazzeo. (2012) Quantitation of pH-induced Aggregation in Binary Protein Mixtures by Dielectric Spectroscopy. The Protein Journal 31:8, pages 703-709.
Crossref
Crossref
Andrea Hawe, Stefan Romeijn, Vasco Filipe & Wim Jiskoot. (2012) Asymmetrical Flow Field-Flow Fractionation Method for the Analysis of Submicron Protein Aggregates. Journal of Pharmaceutical Sciences 101:11, pages 4129-4139.
Crossref
Crossref
Ozan S. Kumru, Jun Liu, Junyan A. Ji, Wilson Cheng, Y. John Wang, Tingting Wang, Sangeeta B. Joshi, C. Russell Middaugh & David B. Volkin. (2012) Compatibility, Physical Stability, and Characterization of an IgG4 Monoclonal Antibody After Dilution into Different Intravenous Administration Bags. Journal of Pharmaceutical Sciences 101:10, pages 3636-3650.
Crossref
Crossref
Rajsekhar Paul, Alexandra Graff-Meyer, Henning Stahlberg, Matthias E. Lauer, Arne C. Rufer, Hermann Beck, Alexandre Briguet, Volker Schnaible, Thomas Buckel & Sabine Boeckle. (2012) Structure and Function of Purified Monoclonal Antibody Dimers Induced by Different Stress Conditions. Pharmaceutical Research 29:8, pages 2047-2059.
Crossref
Crossref
Tapan K. Das. (2012) Protein Particulate Detection Issues in Biotherapeutics Development—Current Status. AAPS PharmSciTech 13:2, pages 732-746.
Crossref
Crossref
Sarah Zölls, Ruedeeporn Tantipolphan, Michael Wiggenhorn, Gerhard Winter, Wim Jiskoot, Wolfgang Friess & Andrea Hawe. (2012) Particles in Therapeutic Protein Formulations, Part 1: Overview of Analytical Methods. Journal of Pharmaceutical Sciences 101:3, pages 914-935.
Crossref
Crossref
Henryk Mach, Brian K. Meyer & Mohammed Shameem. 2012. Therapeutic Protein Drug Products. Therapeutic Protein Drug Products
47
65
.
E. Patois, M.A.H. Capelle, C. Palais, R. Gurny & T. Arvinte. (2012) Evaluation of nanoparticle tracking analysis (NTA) in the characterization of therapeutic antibodies and seasonal influenza vaccines: pros and cons. Journal of Drug Delivery Science and Technology 22:5, pages 427-433.
Crossref
Crossref
Caroline Palais, Martinus Capelle & Tudor Arvinte. 2012. Field-Flow Fractionation in Biopolymer Analysis. Field-Flow Fractionation in Biopolymer Analysis
103
112
.
Christopher J. Roberts, Tapan K. Das & Erinc Sahin. (2011) Predicting solution aggregation rates for therapeutic proteins: Approaches and challenges. International Journal of Pharmaceutics 418:2, pages 318-333.
Crossref
Crossref
Henryk Mach & Tudor Arvinte. (2011) Addressing new analytical challenges in protein formulation development. European Journal of Pharmaceutics and Biopharmaceutics 78:2, pages 196-207.
Crossref
Crossref
Henryk Mach, Akhilesh Bhambhani, Brian K. Meyer, Steven Burek, Harrison Davis, Jeffrey T. Blue & Robert K. Evans. (2011) The Use of Flow Cytometry for the Detection of Subvisible Particles in Therapeutic Protein Formulations. Journal of Pharmaceutical Sciences 100:5, pages 1671-1678.
Crossref
Crossref